ResearcherUniversity of MilanNo recent work listed

Giuseppe Viale

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1882-7068; OpenAlex author ID A5088697304. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 1 paper

Papers 1

Phase II study (KAMELEON) of single-agent T-DM1 in patients with HER2-positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma. Last author DOI 10.1002/cam4.5893 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Emile E. Voest · 1 shared paper, 2023 · strength 0.16
- Paper Phase II study (KAMELEON) of single-agent T-DM1 in patients with HER2-positive advanced urothelial bladder cancer or pa… DOI 10.1002/cam4.5893 ↗
Luca Gianni · 1 shared paper, 2023 · strength 0.16
- Paper Phase II study (KAMELEON) of single-agent T-DM1 in patients with HER2-positive advanced urothelial bladder cancer or pa… DOI 10.1002/cam4.5893 ↗
Josep M. Tabernero · 1 shared paper, 2023 · strength 0.16
- Paper Phase II study (KAMELEON) of single-agent T-DM1 in patients with HER2-positive advanced urothelial bladder cancer or pa… DOI 10.1002/cam4.5893 ↗
Elisabeth G.E. de Vries · 1 shared paper, 2023 · strength 0.16
- Paper Phase II study (KAMELEON) of single-agent T-DM1 in patients with HER2-positive advanced urothelial bladder cancer or pa… DOI 10.1002/cam4.5893 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.